tiprankstipranks
APONTIS PHARMA AG (DE:APPH)
:APPH
Germany Market

APONTIS PHARMA AG (APPH) Financial Statements

Compare
6 Followers

APONTIS PHARMA AG Financial Overview

APONTIS PHARMA AG's market cap is currently €96.05M. The company's EPS TTM is €-0.849; its P/E ratio is ―; APONTIS PHARMA AG is scheduled to report earnings on March 6, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue€ 36.96M€ 55.73M€ 51.18M€ 39.24M€ 40.04M
Gross Profit€ 23.17M€ 34.99M€ 33.79M€ 25.03M€ 28.97M
Operating Income€ -15.10M€ 5.67M€ 1.67M--
EBITDA€ -12.94M€ 5.67M€ 1.99M€ 1.04M-
Net Income€ -11.30M€ 2.69M---
Balance Sheet
Cash & Short-Term Investments€ 26.82M€ 36.35M€ 29.84M€ 8.06M€ 7.39M
Total Assets€ 57.46M€ 59.85M€ 54.13M€ 29.69M€ 30.59M
Total Debt€ 6.02M€ 0.00€ 0.00€ 0.00€ 0.00
Net Debt-€ -36.35M€ -29.84M€ -8.06M€ -7.39M
Total Liabilities€ 27.20M€ 18.29M€ 13.42M€ 26.23M€ 25.94M
Stockholders' Equity€ 30.26M€ 41.57M€ 40.71M€ 3.46M€ 4.64M
Cash Flow
Free Cash Flow-€ 7.74M€ 1.77M€ 721.45K-
Operating Cash Flow€ -12.60M€ 11.02M€ 3.43M€ 1.45M-
Investing Cash Flow€ -2.90M----
Financing Cash Flow€ 6.00M-€ 20.12M--
Currency in EUR

APONTIS PHARMA AG Earnings and Revenue History

APONTIS PHARMA AG Debt to Assets

APONTIS PHARMA AG Cash Flow

APONTIS PHARMA AG Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis